ask="19.68"
ask_size="200"
average_daily_volume="142403"
bid="12.00"
bid_size="100"
book_value="6.55"
change="+0.42"
change_from_200_day_moving_average="2.67"
change_from_50_day_moving_average="1.87"
change_from_52_week_high="-1.00"
change_From_52_week_low="6.43"
change_in_percent="+2.32%"
close="18.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.01"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.06"
ex_dividend_date="N/A"
float_shares="11581000"
high="19.05"
high_52_weeks="19.50"
last_trade_date="2/28/2017"
last_trade_price="18.50"
last_trade_size="8204"
last_trade_time="4:00pm"
low="17.82"
low_52_weeks="12.07"
market_capitalization="406.67M"
moving_average_200_day="15.83"
moving_average_50_day="16.63"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.83"
open="18.08"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+16.90%"
percent_change_from_50_day_moving_average="+11.23%"
percent_change_from_52_week_high="-5.13%"
percent_change_from_52_week_low="+53.27%"
previous_close="18.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.76"
price_per_sales="375.29"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="19.33"
stock_exchange="NGM"
symbol="ADMS"
volume="299241"
weeks_range_52="12.07 - 19.50"
